WATSON 3159 (Ursodiol 300 mg)
Pill imprint WATSON 3159 has been identified as Ursodiol 300 mg.
Ursodiol is used in the treatment of biliary cirrhosis; nonalcoholic fatty liver disease; gallbladder disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WATSON 3159
- 300 mg
- 22.00 mm
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|68084-0213||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about ursodiol
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.